Loading…

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation

Background Tardive dyskinesia (TD), a movement disorder in which patients experience abnormal involuntary movements, can have profound negative impacts on physical, cognitive, and psychosocial functioning. The Abnormal Involuntary Movement Scale (AIMS), a clinician-rated outcome, is considered the g...

Full description

Saved in:
Bibliographic Details
Published in:Journal of patient-reported outcomes 2024-01, Vol.8 (1), p.2-2, Article 2
Main Authors: Farber, Robert H., Stull, Donald E., Witherspoon, Brooke, Evans, Christopher J., Yonan, Charles, Bron, Morgan, Dhanda, Rahul, Jen, Eric, Brien, Christopher O.’
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c503t-7ce388c75d6de3bd7800175db336403741479900356b3556c99f8c536594c5023
container_end_page 2
container_issue 1
container_start_page 2
container_title Journal of patient-reported outcomes
container_volume 8
creator Farber, Robert H.
Stull, Donald E.
Witherspoon, Brooke
Evans, Christopher J.
Yonan, Charles
Bron, Morgan
Dhanda, Rahul
Jen, Eric
Brien, Christopher O.’
description Background Tardive dyskinesia (TD), a movement disorder in which patients experience abnormal involuntary movements, can have profound negative impacts on physical, cognitive, and psychosocial functioning. The Abnormal Involuntary Movement Scale (AIMS), a clinician-rated outcome, is considered the gold standard for evaluating treatment efficacy in TD clinical trials. However, it provides little information about the impacts of uncontrolled movements from a patient perspective and can be cumbersome to administer in clinical settings. The Tardive Dyskinesia Impact Scale (TDIS) was developed as a patient-reported outcome measure to fulfill the need for a disease-specific impact assessment in TD. The objective of the present study was to develop and evaluate the psychometric properties of the TDIS to determine whether it is fit-for-purpose to measure TD impact. Methods Data from qualitative studies and phase 3 trials of a VMAT2 inhibitor for the treatment of TD (KINECT3 and KINECT4) were used to determine the psychometric properties of the TDIS. Qualitative research included concept elicitation and cognitive debriefing interviews with TD patients and their caregivers in order to assess how well the TDIS captured key domains of TD impact. Quantitative analyses to examine the psychometric properties of the TDIS included assessing construct validity (factor structure, known groups, and predictive validity) and responsiveness to change. Results Qualitative results showed that the TDIS captures the key TD impacts reported by patients and caregivers and that the TDIS was interpreted as intended and relevant to patients’ experiences. Quantitative results found evidence of 2 underlying domains of the TDIS: physical and socioemotional (Comparative Fit Index > 0.9). Known groups and predictive validity indicated that, compared with the AIMS, the TDIS captures unique content (correlation between AIMS and TDIS = 0.2–0.28). The TDIS showed responsiveness to change in treatment, with TDIS scores improving over 48 weeks in the 2 phase 3 trials. Conclusions The TDIS captures relevant information about the impact of TD and is easily administered in a clinician’s office or patient’s home. It may be used longitudinally to show changes in TD burden over time. The TDIS complements the AIMS; using these assessments together provides a more holistic assessment of TD. Plain English summary Tardive dyskinesia is a condition where people have uncontrollable movements because of taking
doi_str_mv 10.1186/s41687-023-00679-4
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9f7b627db5b64a22bdb11bbc59c716f3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9f7b627db5b64a22bdb11bbc59c716f3</doaj_id><sourcerecordid>2910195661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-7ce388c75d6de3bd7800175db336403741479900356b3556c99f8c536594c5023</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhSMEotXQF2CBLLEpUgN2HNsxO9QWGKkSiw5ryz83rYckDnYy0jwHL4yZDANigWTJf-d89rFvUbwk-C0hDX-XasIbUeKKlhhzIcv6SXFeMSzLBlf46V_js-IipS3GmEgpmaTPizPaEMFqhs-LH5tHQBsdnd8Butmnb36A5DVa96O2E7q3ugN0ublZ37-5QhoNYQcdGvXkYZjKCGOIEzgU5smGHlAPOs0RkB_QdGS6E_M9cpDdYeyzF-nBoTHt7WP2TdFbtNOddxkchhfFs1Z3CS6O_ar4-vF2c_25vPvyaX394a60DNOpFBZo01jBHHdAjRNNjphnhlJeYypqUgspMaaMG8oYt1K2jWWUM1lnQkVXxXrhuqC3aoy-13GvgvbqsBDig9Jx8rYDJVtheCWcYYbXuqqMM4QYY5m0gvCWZtblwhpj-D5DmlTvk4Wu0wOEOalKkvz-jHOSpa__kW7DHIec9KDCNae5rYpqUdkYUorQni5IsPpVAWqpAJWDqEMFqDqbXh3Rs-nBnSy__zsL6CJIeWt4gPjn7P9gfwKOu7sn</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2910046346</pqid></control><display><type>article</type><title>The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access</source><creator>Farber, Robert H. ; Stull, Donald E. ; Witherspoon, Brooke ; Evans, Christopher J. ; Yonan, Charles ; Bron, Morgan ; Dhanda, Rahul ; Jen, Eric ; Brien, Christopher O.’</creator><creatorcontrib>Farber, Robert H. ; Stull, Donald E. ; Witherspoon, Brooke ; Evans, Christopher J. ; Yonan, Charles ; Bron, Morgan ; Dhanda, Rahul ; Jen, Eric ; Brien, Christopher O.’</creatorcontrib><description>Background Tardive dyskinesia (TD), a movement disorder in which patients experience abnormal involuntary movements, can have profound negative impacts on physical, cognitive, and psychosocial functioning. The Abnormal Involuntary Movement Scale (AIMS), a clinician-rated outcome, is considered the gold standard for evaluating treatment efficacy in TD clinical trials. However, it provides little information about the impacts of uncontrolled movements from a patient perspective and can be cumbersome to administer in clinical settings. The Tardive Dyskinesia Impact Scale (TDIS) was developed as a patient-reported outcome measure to fulfill the need for a disease-specific impact assessment in TD. The objective of the present study was to develop and evaluate the psychometric properties of the TDIS to determine whether it is fit-for-purpose to measure TD impact. Methods Data from qualitative studies and phase 3 trials of a VMAT2 inhibitor for the treatment of TD (KINECT3 and KINECT4) were used to determine the psychometric properties of the TDIS. Qualitative research included concept elicitation and cognitive debriefing interviews with TD patients and their caregivers in order to assess how well the TDIS captured key domains of TD impact. Quantitative analyses to examine the psychometric properties of the TDIS included assessing construct validity (factor structure, known groups, and predictive validity) and responsiveness to change. Results Qualitative results showed that the TDIS captures the key TD impacts reported by patients and caregivers and that the TDIS was interpreted as intended and relevant to patients’ experiences. Quantitative results found evidence of 2 underlying domains of the TDIS: physical and socioemotional (Comparative Fit Index &gt; 0.9). Known groups and predictive validity indicated that, compared with the AIMS, the TDIS captures unique content (correlation between AIMS and TDIS = 0.2–0.28). The TDIS showed responsiveness to change in treatment, with TDIS scores improving over 48 weeks in the 2 phase 3 trials. Conclusions The TDIS captures relevant information about the impact of TD and is easily administered in a clinician’s office or patient’s home. It may be used longitudinally to show changes in TD burden over time. The TDIS complements the AIMS; using these assessments together provides a more holistic assessment of TD. Plain English summary Tardive dyskinesia is a condition where people have uncontrollable movements because of taking certain medications for a long time. It is still poorly understood how these uncontrollable movements affect a person’s everyday activities. We created a questionnaire called the Tardive Dyskinesia Impact Scale (TDIS). The TDIS is a questionnaire where people with tardive dyskinesia rate how their symptoms affect daily activities such as speaking and walking. People can also rate how the uncontrollable movements make them feel. We used specific tests called psychometric tests to see if the TDIS measures the correct information and if the information is reliable. Findings from this study show that the TDIS is a good way to measure how a person’s uncontrollable movements affect everyday activities. The results also show that when people take medicine to help with their symptoms, their TDIS scores are better. When patients stopped taking the medicine, their symptoms were worse, and their TDIS score was worse. The TDIS can help people explain how their uncontrollable movements affect their daily life. This can then help their doctors understand the person’s condition better.</description><identifier>ISSN: 2509-8020</identifier><identifier>EISSN: 2509-8020</identifier><identifier>DOI: 10.1186/s41687-023-00679-4</identifier><identifier>PMID: 38175450</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Caregivers ; Clinical outcomes ; Dyskinesia ; Dyskinesias ; Humans ; Medicine ; Medicine &amp; Public Health ; Movement Disorders ; Patient Reported Outcome Measures ; Patient-reported outcomes ; Patients ; Psychometrics ; Qualitative research ; Quality of Life Research ; Quantitative psychology ; Questionnaires ; Tardive dyskinesia ; Tardive Dyskinesia - diagnosis ; Validation ; Validity</subject><ispartof>Journal of patient-reported outcomes, 2024-01, Vol.8 (1), p.2-2, Article 2</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c503t-7ce388c75d6de3bd7800175db336403741479900356b3556c99f8c536594c5023</cites><orcidid>0000-0002-2496-3501</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2910046346?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38175450$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Farber, Robert H.</creatorcontrib><creatorcontrib>Stull, Donald E.</creatorcontrib><creatorcontrib>Witherspoon, Brooke</creatorcontrib><creatorcontrib>Evans, Christopher J.</creatorcontrib><creatorcontrib>Yonan, Charles</creatorcontrib><creatorcontrib>Bron, Morgan</creatorcontrib><creatorcontrib>Dhanda, Rahul</creatorcontrib><creatorcontrib>Jen, Eric</creatorcontrib><creatorcontrib>Brien, Christopher O.’</creatorcontrib><title>The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation</title><title>Journal of patient-reported outcomes</title><addtitle>J Patient Rep Outcomes</addtitle><addtitle>J Patient Rep Outcomes</addtitle><description>Background Tardive dyskinesia (TD), a movement disorder in which patients experience abnormal involuntary movements, can have profound negative impacts on physical, cognitive, and psychosocial functioning. The Abnormal Involuntary Movement Scale (AIMS), a clinician-rated outcome, is considered the gold standard for evaluating treatment efficacy in TD clinical trials. However, it provides little information about the impacts of uncontrolled movements from a patient perspective and can be cumbersome to administer in clinical settings. The Tardive Dyskinesia Impact Scale (TDIS) was developed as a patient-reported outcome measure to fulfill the need for a disease-specific impact assessment in TD. The objective of the present study was to develop and evaluate the psychometric properties of the TDIS to determine whether it is fit-for-purpose to measure TD impact. Methods Data from qualitative studies and phase 3 trials of a VMAT2 inhibitor for the treatment of TD (KINECT3 and KINECT4) were used to determine the psychometric properties of the TDIS. Qualitative research included concept elicitation and cognitive debriefing interviews with TD patients and their caregivers in order to assess how well the TDIS captured key domains of TD impact. Quantitative analyses to examine the psychometric properties of the TDIS included assessing construct validity (factor structure, known groups, and predictive validity) and responsiveness to change. Results Qualitative results showed that the TDIS captures the key TD impacts reported by patients and caregivers and that the TDIS was interpreted as intended and relevant to patients’ experiences. Quantitative results found evidence of 2 underlying domains of the TDIS: physical and socioemotional (Comparative Fit Index &gt; 0.9). Known groups and predictive validity indicated that, compared with the AIMS, the TDIS captures unique content (correlation between AIMS and TDIS = 0.2–0.28). The TDIS showed responsiveness to change in treatment, with TDIS scores improving over 48 weeks in the 2 phase 3 trials. Conclusions The TDIS captures relevant information about the impact of TD and is easily administered in a clinician’s office or patient’s home. It may be used longitudinally to show changes in TD burden over time. The TDIS complements the AIMS; using these assessments together provides a more holistic assessment of TD. Plain English summary Tardive dyskinesia is a condition where people have uncontrollable movements because of taking certain medications for a long time. It is still poorly understood how these uncontrollable movements affect a person’s everyday activities. We created a questionnaire called the Tardive Dyskinesia Impact Scale (TDIS). The TDIS is a questionnaire where people with tardive dyskinesia rate how their symptoms affect daily activities such as speaking and walking. People can also rate how the uncontrollable movements make them feel. We used specific tests called psychometric tests to see if the TDIS measures the correct information and if the information is reliable. Findings from this study show that the TDIS is a good way to measure how a person’s uncontrollable movements affect everyday activities. The results also show that when people take medicine to help with their symptoms, their TDIS scores are better. When patients stopped taking the medicine, their symptoms were worse, and their TDIS score was worse. The TDIS can help people explain how their uncontrollable movements affect their daily life. This can then help their doctors understand the person’s condition better.</description><subject>Caregivers</subject><subject>Clinical outcomes</subject><subject>Dyskinesia</subject><subject>Dyskinesias</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Movement Disorders</subject><subject>Patient Reported Outcome Measures</subject><subject>Patient-reported outcomes</subject><subject>Patients</subject><subject>Psychometrics</subject><subject>Qualitative research</subject><subject>Quality of Life Research</subject><subject>Quantitative psychology</subject><subject>Questionnaires</subject><subject>Tardive dyskinesia</subject><subject>Tardive Dyskinesia - diagnosis</subject><subject>Validation</subject><subject>Validity</subject><issn>2509-8020</issn><issn>2509-8020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1u1DAUhSMEotXQF2CBLLEpUgN2HNsxO9QWGKkSiw5ryz83rYckDnYy0jwHL4yZDANigWTJf-d89rFvUbwk-C0hDX-XasIbUeKKlhhzIcv6SXFeMSzLBlf46V_js-IipS3GmEgpmaTPizPaEMFqhs-LH5tHQBsdnd8Butmnb36A5DVa96O2E7q3ugN0ublZ37-5QhoNYQcdGvXkYZjKCGOIEzgU5smGHlAPOs0RkB_QdGS6E_M9cpDdYeyzF-nBoTHt7WP2TdFbtNOddxkchhfFs1Z3CS6O_ar4-vF2c_25vPvyaX394a60DNOpFBZo01jBHHdAjRNNjphnhlJeYypqUgspMaaMG8oYt1K2jWWUM1lnQkVXxXrhuqC3aoy-13GvgvbqsBDig9Jx8rYDJVtheCWcYYbXuqqMM4QYY5m0gvCWZtblwhpj-D5DmlTvk4Wu0wOEOalKkvz-jHOSpa__kW7DHIec9KDCNae5rYpqUdkYUorQni5IsPpVAWqpAJWDqEMFqDqbXh3Rs-nBnSy__zsL6CJIeWt4gPjn7P9gfwKOu7sn</recordid><startdate>20240104</startdate><enddate>20240104</enddate><creator>Farber, Robert H.</creator><creator>Stull, Donald E.</creator><creator>Witherspoon, Brooke</creator><creator>Evans, Christopher J.</creator><creator>Yonan, Charles</creator><creator>Bron, Morgan</creator><creator>Dhanda, Rahul</creator><creator>Jen, Eric</creator><creator>Brien, Christopher O.’</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><general>SpringerOpen</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>KB0</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2496-3501</orcidid></search><sort><creationdate>20240104</creationdate><title>The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation</title><author>Farber, Robert H. ; Stull, Donald E. ; Witherspoon, Brooke ; Evans, Christopher J. ; Yonan, Charles ; Bron, Morgan ; Dhanda, Rahul ; Jen, Eric ; Brien, Christopher O.’</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-7ce388c75d6de3bd7800175db336403741479900356b3556c99f8c536594c5023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Caregivers</topic><topic>Clinical outcomes</topic><topic>Dyskinesia</topic><topic>Dyskinesias</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Movement Disorders</topic><topic>Patient Reported Outcome Measures</topic><topic>Patient-reported outcomes</topic><topic>Patients</topic><topic>Psychometrics</topic><topic>Qualitative research</topic><topic>Quality of Life Research</topic><topic>Quantitative psychology</topic><topic>Questionnaires</topic><topic>Tardive dyskinesia</topic><topic>Tardive Dyskinesia - diagnosis</topic><topic>Validation</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farber, Robert H.</creatorcontrib><creatorcontrib>Stull, Donald E.</creatorcontrib><creatorcontrib>Witherspoon, Brooke</creatorcontrib><creatorcontrib>Evans, Christopher J.</creatorcontrib><creatorcontrib>Yonan, Charles</creatorcontrib><creatorcontrib>Bron, Morgan</creatorcontrib><creatorcontrib>Dhanda, Rahul</creatorcontrib><creatorcontrib>Jen, Eric</creatorcontrib><creatorcontrib>Brien, Christopher O.’</creatorcontrib><collection>SpringerOpen (Open Access)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals (Open Access)</collection><jtitle>Journal of patient-reported outcomes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farber, Robert H.</au><au>Stull, Donald E.</au><au>Witherspoon, Brooke</au><au>Evans, Christopher J.</au><au>Yonan, Charles</au><au>Bron, Morgan</au><au>Dhanda, Rahul</au><au>Jen, Eric</au><au>Brien, Christopher O.’</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation</atitle><jtitle>Journal of patient-reported outcomes</jtitle><stitle>J Patient Rep Outcomes</stitle><addtitle>J Patient Rep Outcomes</addtitle><date>2024-01-04</date><risdate>2024</risdate><volume>8</volume><issue>1</issue><spage>2</spage><epage>2</epage><pages>2-2</pages><artnum>2</artnum><issn>2509-8020</issn><eissn>2509-8020</eissn><abstract>Background Tardive dyskinesia (TD), a movement disorder in which patients experience abnormal involuntary movements, can have profound negative impacts on physical, cognitive, and psychosocial functioning. The Abnormal Involuntary Movement Scale (AIMS), a clinician-rated outcome, is considered the gold standard for evaluating treatment efficacy in TD clinical trials. However, it provides little information about the impacts of uncontrolled movements from a patient perspective and can be cumbersome to administer in clinical settings. The Tardive Dyskinesia Impact Scale (TDIS) was developed as a patient-reported outcome measure to fulfill the need for a disease-specific impact assessment in TD. The objective of the present study was to develop and evaluate the psychometric properties of the TDIS to determine whether it is fit-for-purpose to measure TD impact. Methods Data from qualitative studies and phase 3 trials of a VMAT2 inhibitor for the treatment of TD (KINECT3 and KINECT4) were used to determine the psychometric properties of the TDIS. Qualitative research included concept elicitation and cognitive debriefing interviews with TD patients and their caregivers in order to assess how well the TDIS captured key domains of TD impact. Quantitative analyses to examine the psychometric properties of the TDIS included assessing construct validity (factor structure, known groups, and predictive validity) and responsiveness to change. Results Qualitative results showed that the TDIS captures the key TD impacts reported by patients and caregivers and that the TDIS was interpreted as intended and relevant to patients’ experiences. Quantitative results found evidence of 2 underlying domains of the TDIS: physical and socioemotional (Comparative Fit Index &gt; 0.9). Known groups and predictive validity indicated that, compared with the AIMS, the TDIS captures unique content (correlation between AIMS and TDIS = 0.2–0.28). The TDIS showed responsiveness to change in treatment, with TDIS scores improving over 48 weeks in the 2 phase 3 trials. Conclusions The TDIS captures relevant information about the impact of TD and is easily administered in a clinician’s office or patient’s home. It may be used longitudinally to show changes in TD burden over time. The TDIS complements the AIMS; using these assessments together provides a more holistic assessment of TD. Plain English summary Tardive dyskinesia is a condition where people have uncontrollable movements because of taking certain medications for a long time. It is still poorly understood how these uncontrollable movements affect a person’s everyday activities. We created a questionnaire called the Tardive Dyskinesia Impact Scale (TDIS). The TDIS is a questionnaire where people with tardive dyskinesia rate how their symptoms affect daily activities such as speaking and walking. People can also rate how the uncontrollable movements make them feel. We used specific tests called psychometric tests to see if the TDIS measures the correct information and if the information is reliable. Findings from this study show that the TDIS is a good way to measure how a person’s uncontrollable movements affect everyday activities. The results also show that when people take medicine to help with their symptoms, their TDIS scores are better. When patients stopped taking the medicine, their symptoms were worse, and their TDIS score was worse. The TDIS can help people explain how their uncontrollable movements affect their daily life. This can then help their doctors understand the person’s condition better.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>38175450</pmid><doi>10.1186/s41687-023-00679-4</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-2496-3501</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2509-8020
ispartof Journal of patient-reported outcomes, 2024-01, Vol.8 (1), p.2-2, Article 2
issn 2509-8020
2509-8020
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9f7b627db5b64a22bdb11bbc59c716f3
source PubMed Central (Open Access); Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access
subjects Caregivers
Clinical outcomes
Dyskinesia
Dyskinesias
Humans
Medicine
Medicine & Public Health
Movement Disorders
Patient Reported Outcome Measures
Patient-reported outcomes
Patients
Psychometrics
Qualitative research
Quality of Life Research
Quantitative psychology
Questionnaires
Tardive dyskinesia
Tardive Dyskinesia - diagnosis
Validation
Validity
title The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A29%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Tardive%20Dyskinesia%20Impact%20Scale%20(TDIS),%20a%20novel%20patient-reported%20outcome%20measure%20in%20tardive%20dyskinesia:%20development%20and%20psychometric%20validation&rft.jtitle=Journal%20of%20patient-reported%20outcomes&rft.au=Farber,%20Robert%20H.&rft.date=2024-01-04&rft.volume=8&rft.issue=1&rft.spage=2&rft.epage=2&rft.pages=2-2&rft.artnum=2&rft.issn=2509-8020&rft.eissn=2509-8020&rft_id=info:doi/10.1186/s41687-023-00679-4&rft_dat=%3Cproquest_doaj_%3E2910195661%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c503t-7ce388c75d6de3bd7800175db336403741479900356b3556c99f8c536594c5023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2910046346&rft_id=info:pmid/38175450&rfr_iscdi=true